These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 987190)

  • 21. [Treatment of angina pectoris with a new pyrimido-pyrimidine derivative, Persantin. Clinical experience with the double-blind control technic].
    ROMAN O; SAFFIE F
    Rev Med Chil; 1963 Apr; 91():273-9. PubMed ID: 13982572
    [No Abstract]   [Full Text] [Related]  

  • 22. [Pyrimidine derivatives. VI. Studies on the syntheses of orotic acid, uracil and pyrimido(5,4-d)pyrimidine derivatives].
    Okui K; Mizoguchi M
    Yakugaku Zasshi; 1972 Jul; 92(7):785-95. PubMed ID: 4676215
    [No Abstract]   [Full Text] [Related]  

  • 23. [BEHAVIOR OF CEREBRAL BLOOD FLOW AND METABOLISM AFTER ADMINISTRATION OF 2,6 BIS-(DIETHANOLAMINO)-4,8 DIPIPERIDINO-PYRIMIDO(5,4 D)-PYRIMIDINE].
    DELLAPORTA P; MAIOLO AT; ROSSELLA E
    Gazz Med Ital; 1963 Jul; 122():201-3. PubMed ID: 14047340
    [No Abstract]   [Full Text] [Related]  

  • 24. [THE EFFECT OF 2,6-BIS(DIETHANOLAMINO)-4,8-DIPIPERDINO-PYRIMIDO(5,4-D)PYRIMIDINE(PERSANTIN) ON THE CORONARY CIRCULATION, OXYGEN UPTAKE AND SUBSTRATE UPTAKE OF THE HUMAN HEART].
    RUDOLPH W; BERNSMEIER A; HENSELMANN L; BAEDEKER WD; HOFMANN H
    Klin Wochenschr; 1964 Jul; 42():667-74. PubMed ID: 14250907
    [No Abstract]   [Full Text] [Related]  

  • 25. The pyrimido-pyrimidine derivative RA-642: a potent inhibitor of ferrous-induced lipid peroxidation in cell membranes.
    Bellido I; de la Cruz JP; Sánchez de la Cuesta F
    Methods Find Exp Clin Pharmacol; 1991; 13(6):371-5. PubMed ID: 1881198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of pyrimido[5,4-d]pyrimidine derivatives as peroxyoxalate chemiluminescence reagents using a flow injection system.
    Nakashima K; Maki K; Akiyama S; Imai K
    Biomed Chromatogr; 1990 May; 4(3):105-7. PubMed ID: 2383690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Action of a pyrimido-pyrimidine compound on platelet behaviour in vitro.
    Forbes CD; McNicol GP; Douglas AS
    Br Med J; 1969 May; 2(5655):483-5. PubMed ID: 5771580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of the coronary patient with a pyrimido-pyrimidine derivative].
    VUYLSTEEK K; COLLE R; LAURIJSSENS M; VAN DER STRAETEN M
    Belg Tijdschr Geneesk; 1962 Sep; 18():884-99. PubMed ID: 13998071
    [No Abstract]   [Full Text] [Related]  

  • 29. [THERAPEUTIC ACTION OF A DERIVATIVE OF PYRIMIDO-PYRIMIDINE IN A SIMPLE AND SEDATIVE FORM IN CORONARY INSUFFICIENCY].
    LAI L; COLLICELLI A
    Minerva Cardioangiol; 1964 Feb; 12():83-7. PubMed ID: 14140221
    [No Abstract]   [Full Text] [Related]  

  • 30. [The distribution of 2,6-bis (diethanolamino)-4,8-dipiperidino-pyrimido-(5,4-d)pyrimidine in organs and in the myocardial cells of rats and mice].
    KUNZ W; MUELLER E; SIESS M
    Arzneimittelforschung; 1963 Mar; 13():179-85. PubMed ID: 13927400
    [No Abstract]   [Full Text] [Related]  

  • 31. [Experimental clinical study of the treatment of patients with hearing disorders using 2,6 bis (diethanolamine) 4,8, dipyperidin pyrimido (5,4-D) pyrimidine].
    Bosch Torrent J
    Rev Esp Otoneurooftalmol Neurocir; 1969-1970; 28(165):285-8. PubMed ID: 5397853
    [No Abstract]   [Full Text] [Related]  

  • 32. [EFFECT OF 2,6-BIS(DIETHANOLAMINO)-4,8-DIPIPERIDINO-PYRIMIDO(5,4-D)PYRIMIDINE ON STIMULATION AND CONTRACTILITY OF ISOLATED PAPPILARY MUSCLES AND A AURICULAR TRABECULAE. (STUDIES ON THE MYOCARDIUM OF APES, CATS, RABBITS, GUNINEA PIGS AND RATS)].
    ANTONI H; ENGSTFELD G; GRETEN H
    Arzneimittelforschung; 1963 Aug; 13():706-11. PubMed ID: 14085925
    [No Abstract]   [Full Text] [Related]  

  • 33. The effects of 2,6-bis(diethanolamino)-4-piperidino-pyrimido(5,4-D)pyrimidine (RA233) on the coronary circulation of the acutely transplanted dog heart: comparison with dipyridamole and adenosine.
    Paoloni HJ; Wilcken DE
    J Pharmacol Exp Ther; 1972 Oct; 183(1):137-45. PubMed ID: 4562619
    [No Abstract]   [Full Text] [Related]  

  • 34. [The effect of 2,6-bis (diethanolamino)-4,8-dipiperidino-pyrimido-(5,4-d)-pyrimidine (Persantin) on the respiration of mitochondria in low O2 pressure].
    FRIMMER M; HEGNER D; WINKELMANN W
    Klin Wochenschr; 1963 Jul; 41():715-6. PubMed ID: 13959882
    [No Abstract]   [Full Text] [Related]  

  • 35. Isolation and characterisation of degradant impurities in dipyridamole formulation.
    Venkata Subbaiah B; Sree Ganesh KK; Vamsi Krishna G; Vyas K; Vasu Dev R; Subramanyam Reddy K
    J Pharm Biomed Anal; 2012 Mar; 61():256-64. PubMed ID: 22206889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Absorption and activity of 2,6-bis-(diethanolamino)-4,8-dipiperidino-pyrimido-(5,4-d) pyrimidine (RA8) following enteric administration.
    Kadatz R; Beisenherz G
    Arch Int Pharmacodyn Ther; 1965 Dec; 158(2):389-402. PubMed ID: 5868589
    [No Abstract]   [Full Text] [Related]  

  • 37. A concise, efficient and versatile synthesis of amino-substituted benzo[b]pyrimido[5,4-f]azepines: synthesis and spectroscopic characterization, together with the molecular and supramolecular structures of three products and one intermediate.
    Acosta Quintero LM; Burgos I; Palma A; Cobo J; Glidewell C
    Acta Crystallogr C Struct Chem; 2018 Mar; 74(Pt 3):312-320. PubMed ID: 29504560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [ALTERATION OF THE MONOSACCHARIDE PERMEABILITY OF HUMAN ERYTHROCYTES BY A PYRIMIDO-PYRIMIDINE COMPOUND].
    DEUTICKE B; DUHM J; GERLACH E
    Pflugers Arch Gesamte Physiol Menschen Tiere; 1964 Jul; 280():275-80. PubMed ID: 14257859
    [No Abstract]   [Full Text] [Related]  

  • 39. [Observations on the treatment of myocardial infarct with 2-6-bis-(diethanolamino)-4,8-dipiperidino-pyrimido-5,4-d)-pyrimidine (Persantin) in slow venous perfusion].
    Marangoni R; Brera V; Ferrari A
    Minerva Cardioangiol; 1966 Jun; 14(6):373-9. PubMed ID: 5917541
    [No Abstract]   [Full Text] [Related]  

  • 40. The absorption and excretion of 2,6-bis(diethanolamino)-4,8-dipiperidino-pyrimido-(5,4-d)pyrimidine after oral administration.
    Beisenherz G; Koss F; Klatt L; Binder B
    Arch Int Pharmacodyn Ther; 1965 Dec; 158(2):380-8. PubMed ID: 5868588
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.